This is a small but striking piece from yesterday’s New York Times—link.
Phil Hughes agreed to a 1-year contract to avoid arbitration. The contract pays him $3.2 million, a raise of $500,000.
There’s nothing notable about a four-year veteran receiving a contract with those dollar figures. But it was the conclusion that caught my attention. It says:
Teams are likely to inquire about Hughes, and the Yankees will be willing to listen to trade offers.
It was only four years ago when Hughes, Joba Chamberlain and Ian Kennedy were in the nascent stages of redefining the Yankees developmental apparatus. They were to be homegrown talent providing competence-to-brilliance at an affordable price.
Of course it didn’t work out that way.
Kennedy was traded and fulfilled expectations in a Diamondbacks uniform. Chamberlain was shuttled between the starting rotation and bullpen and is now recovering from Tommy John surgery, a mere shell of the dominating force and sensation he was on his arrival in 2007. And Hughes was also used as a starter and reliever, saw his velocity drop to levels where he couldn’t get anyone out in early 2011 and returned to some semblance of effectiveness late in the season.
Hughes is a tradable commodity fighting for his spot in the starting rotation with non-existent on-field value. Other teams will be attracted by his age and the hope that he can fulfill that potential away from the usage guidelines imposed upon him by the Yankees, but aside from their own headaches or projects, they’re not going to give up much of anything to get Hughes.
This is why it’s so ludicrous to think that the same Yankees front office is suddenly learning its lessons as they acquire Michael Pineda and Jose Campos from the Mariners for Jesus Montero and Hector Noesi.
The concept that Campos is the “key” to the trade—at 19-years-old and having spent last season in low-A ball—is either delusional or a transparent attempt at propaganda to assuage the anger that Montero was traded at all.
There are some instances in which Cashman gets a pass. Carl Pavano was a disaster that, had it not befallen the Yankees, would’ve hit someone else because there were about four other teams prepared to pay Pavano the same amount of money the Yankees did.
But these examples of dropping the lowest grade haven’t happened often enough to warrant deferring to his or anyone in the organization’s judgment when it comes to pitchers.
Now they’re waiting and following the same trajectory with Manny Banuelos and Dellin Betances as they did with Kennedy, Chamberlain and Hughes. They point to studies—both medical and historical—to validate the babying that’s gone on since both joined the organization.
Is it paranoia?
Is it fear?
Is it arrogance?
Is it a calculating desire on the part of the GM to accrue the credit that the likes of Theo Epstein has for being a “genius”?
Any reason is an explanation.
I’d be very concerned if Cashman is doing these things because he thinks they’re the right way to go about nursing a pitcher to the majors. That would indicate a total obliviousness to what’s happened right in front of his eyes to all of these starting pitchers who will go on his ledger as, at best, disappointments. The mandates on innings and pitch counts not only hindered the development of the three pitchers from 2008, but both Hughes and Chamberlain got hurt in spite of them.
They couldn’t pitch effectively and didn’t stay healthy, so what was the point?
Some refer to the development of Ivan Nova as “proof” that the Yankees can nurture pitchers. But Nova was never considered a prospect and the Yankees repeatedly left him exposed to other clubs. Nova was selected by the Padres in the Rule 5 draft of December 2008 only to be returned to the Yankees the next spring. They didn’t know what he was and as recently as last season, they sent him to the minors as the odd man out when they had too many starting pitchers.
Was it so hard to look at Nova and see something different? Didn’t it impress the organization when he buzzed Jose Bautista and Bautista took a few steps toward the mound attempting to intimidate the rookie and Nova didn’t back down an inch?
There are aspects to pitching more important than high draft status a dazzling array of stuff. Nova’s fearless. That counts for something.
Is it poor recognition skills or did they want to bolster the pitchers that were “supposed” to be the centerpieces?
Cashman was once adept at speaking to the media, saying three notebook pages worth of stuff, yet saying nothing at all. As he’s aged, he’s dispatched the circular dialogue sprinkled with non-committal corporate terminology to allocate blame and place the onus on players in an unfair manner.
Feliciano’s shoulder injury was left at the door of the Mets when Cashman said the pitcher had been “abused”. Mets pitching coach Dan Warthen shot back asking how the Yankees didn’t know about Feliciano’s workload before they signed him.
A few days ago ESPN’s Jim Bowden revealed this Cashman analysis of Pineda:
Brian Cashman told me last night that Michael Pineda better improve the change-up & develop into a #1 starter or he will have made a mistake
Is Cashman really putting that yoke around the neck of a 23-year-old as he enters a new clubhouse to stand behind CC Sabathia in the starting rotation, pitching for a team and fanbase to whom anything less than a World Series win is considered disastrous?
I would not have traded Montero and Noesi for Pineda and Campos. I would have done as the Yankees did simultaneously to the trade being announced and signed Hiroki Kuroda and moved forward with what I had. Unless Cashman has something else on the burner, his reservations about Pineda and blustery proclamations about Montero made it too high risk a decision to feel good about. If he doesn’t feel cocksure about Pineda, how does he justify trading a bat he valued so highly?
Those who are trying to play up the inclusion of Campos as important had better look at the Yankees history of pitchers and how many of them have fulfilled the hype—not the promise, but the hype.
It’s right there in black and white, on the medical reports and in the trade buzz.
If you’re thinking that Campos is their new discovery and saving grace for a risky trade, you’d better look at history and think again.